Accuracy of current ASGE guideline and predictive parameters for choledocholithiasis before Endoscopic retrograde cholangiopancreatography

Accuracy of current ASGE guideline and predictive parameters for choledocholithiasis before Endoscopic retrograde cholangiopancreaticography

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220419003

Enrollment

500

Registered

2022-04-19

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

suspected choledocholithiasis treated by Endoscopic retrograde cholangiopancreatography (ERCP) CBD stones Choledocholithiasis Acute cholangitis Biliary pancreatitis ERCP

Interventions

All the patients referred for ERCP. Those with clinical suspicion for choledocholithiasis were included in the study. The inclusion criteria were biliary pain, suspected ascending cholangitis, suspect

Diagnostic

Patients with suspected choledocholithiasis

Eligibility

Sex/Gender

All

Age

1 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with clinically suspected choledocholithiasis, admitted in service of Department of Surgery, Thammasat University Hospital

Exclusion criteria

Exclusion criteria: patients underwent previous ERCP

Design outcomes

Primary

Measure	Time frame
CBD stone at ERCP procedure ERCP finding	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactEkkapak Sriussadaporn

Department of surgery, Thammasat university

drearthsurg@hotmail.com66846115112

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026